IP Verse

Pharmaceutical Compositions Comprising A Jak Inhibitor - EP3595667B1

PatentPatent Analysis

EP3595667

ALFASIGMA
Application Number
EP18713553A
Filing Date
Mar 12, 2018
Status
Granted And Under Opposition
Nov 17, 2023
Grant Date
Dec 20, 2023
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3439637B1
EP2618819B1
EP2560662B1

Bibliography

The patent EP3595667B1 was granted to Alfasigma on Dec 20, 2023 following the initial filing on Mar 12, 2018 under the application number EP18713553A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

POLPHARMASep 20, 2024ADMISSIBLE
BOTTI & FERRARISep 17, 2024ADMISSIBLE
TEVA PHARMACEUTICALSSep 17, 2024ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents